The enterprise agentic stack is getting a lot of attention right now. Four framework releases in ten days and a Microsoft documentation release have focused the conversation on production infrastructure for workflow automation. Two arXiv preprints appearing this week point in a different direction: domain-specific applications where the design constraint isn’t throughput or enterprise integration but reproducibility and accessibility.
These are research papers, not products. arXiv preprints are not peer-reviewed at the time of publication. The claims below represent the stated research aims and scope of each paper – not verified findings or demonstrated production capabilities.
Reproducibility in clinical medical imaging
A paper appearing on arXiv (2604.21936) proposes an artifact-based agent framework aimed at improving reproducibility in clinical medical imaging workflows. The research scope, as characterized by the paper’s framing, addresses a documented challenge in clinical AI: the difficulty of reproducing results across different imaging systems, institutions, and data conditions. Artifact-based approaches, where agent actions and outputs are treated as traceable, versioned artifacts – are one proposed mechanism for making agentic medical image processing more auditable and reproducible. The full abstract and methodology are available at the arXiv preprint page once the URL is confirmed.
Autonomous indoor navigation for low-vision users
A second paper (arXiv:2604.23970) explores LLM-guided agentic parsing of floor plans to support autonomous indoor navigation for low-vision users. The research examines whether an agentic system can interpret architectural floor plan data and generate navigation guidance, a capability that, if validated, would address a genuine accessibility gap in environments that are not equipped with tactile or auditory wayfinding infrastructure. This is early-stage research exploring whether the approach is viable, not a demonstration that it works at deployment scale.
What to watch
These two papers are research signals, not deployment announcements. The significance isn’t that either capability is production-ready, it’s that agentic research is now appearing in clinical and accessibility contexts where the evaluation criteria are different from enterprise workflow benchmarks. Reproducibility and auditable agent behavior in clinical settings map directly to regulatory expectations for medical AI in both the EU and US. Accessibility-focused agentic navigation sits at the intersection of disability rights requirements and AI capability development. If either research thread matures, it won’t be evaluated on latency or cost, it’ll be evaluated on reliability and safety in high-stakes contexts. That’s a different bar, and researchers are starting to design for it.